Fisfalen M E, Soltani K, Janiga A M, Kawakami Y, Macchia E, Quintans J, DeGroot L J
Department of Medicine, University of Chicago, Illinois 60637.
J Clin Endocrinol Metab. 1990 Jul;71(1):170-8. doi: 10.1210/jcem-71-1-170.
The helper effects of thyroid antigen-specific T-cell clones (TCC) on antibody production by peripheral B-cells were studied and compared with similar effects of self major histocompatibility complex II (MHC-II)-reactive TCC as well as uncloned CD4+ cells. Ten TCC were derived from thyroid tissue or peripheral blood mononuclear cells (PBMC) in patients with Graves' disease. Uncloned CD4+ cells were also obtained from PBMC in patients with autoimmune thyroid disease. All TCC were CD3+/CD4+. B-Cells from patients with mainly high serum levels of microsomal antibodies (McAb) were cultured alone and with either TCC or uncloned CD4+ cells in the presence or absence of thyroid antigens [microsomal antigen/thyroid peroxidase (McAg/TPO) and thyroglobulin (Tg)] or pokeweed mitogen (PWM). Total immunoglobulin G (IgG) and specific thyroid antibodies were measured by enzyme-linked immunosorbent assay. Self MHC-II-reactive TCC induced B-cell production of total IgG and even McAb independent of antigens or PWM. Specific TCC required thyroid antigens to induce antibodies. The optimal McAg/TPO or Tg concentration was 10 ng/mL for total IgG production and 1 ng/mL McAg/TPO for McAb synthesis. The addition of PWM did not affect McAb production, but enhanced total IgG synthesis by B-cells under the influence of some specific TCC. Uncloned CD4+ cells induced both total IgG and McAb synthesis in the presence of PWM. With thyroid antigens, uncloned CD4+ cells induced total IgG synthesis at levels comparable to those of specific TCC, but induced smaller quantities of McAb in the presence of McAg/TPO. Our antigen-specific TCC could, therefore, stimulate specific B-cells to produce thyroid antibodies in vitro. Self MHC-II-reactive TCC could also induce specific antibodies by B-cells. Both self MHC-II-reactive CD4+ cells and antigen-specific CD4 cells may play an important role in the pathogenesis and/or perpetuation of autoimmune thyroid disease.
研究了甲状腺抗原特异性T细胞克隆(TCC)对外周血B细胞抗体产生的辅助作用,并与自身主要组织相容性复合体II(MHC-II)反应性TCC以及未克隆的CD4+细胞的类似作用进行了比较。从格雷夫斯病患者的甲状腺组织或外周血单个核细胞(PBMC)中获得了10个TCC。未克隆的CD4+细胞也取自自身免疫性甲状腺疾病患者的PBMC。所有TCC均为CD3+/CD4+。将主要血清微粒体抗体(McAb)水平较高的患者的B细胞单独培养,并在存在或不存在甲状腺抗原[微粒体抗原/甲状腺过氧化物酶(McAg/TPO)和甲状腺球蛋白(Tg)]或商陆有丝分裂原(PWM)的情况下,与TCC或未克隆的CD4+细胞一起培养。通过酶联免疫吸附测定法测量总免疫球蛋白G(IgG)和特异性甲状腺抗体。自身MHC-II反应性TCC可诱导B细胞产生总IgG,甚至在不依赖抗原或PWM的情况下产生McAb。特异性TCC需要甲状腺抗原才能诱导抗体产生。对于总IgG产生,最佳McAg/TPO或Tg浓度为10 ng/mL,对于McAb合成,最佳McAg/TPO浓度为1 ng/mL。PWM的添加不影响McAb产生,但在某些特异性TCC的影响下增强了B细胞的总IgG合成。未克隆的CD4+细胞在PWM存在的情况下诱导总IgG和McAb合成。在存在甲状腺抗原的情况下,未克隆的CD4+细胞诱导的总IgG合成水平与特异性TCC相当,但在存在McAg/TPO的情况下诱导产生的McAb量较少。因此,我们的抗原特异性TCC可以在体外刺激特异性B细胞产生甲状腺抗体。自身MHC-II反应性TCC也可诱导B细胞产生特异性抗体。自身MHC-II反应性CD4+细胞和抗原特异性CD4细胞可能在自身免疫性甲状腺疾病的发病机制和/或持续存在中起重要作用。